BJDX:NSD-Bluejay Diagnostics Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 1.13

Change

0.00 (0.00)%

Market Cap

USD 0.02B

Volume

0.06M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


BJDX Stock Forecast & Price:
Based on the Bluejay Diagnostics Inc stock forecasts from 0 analysts, the average analyst target price for Bluejay Diagnostics Inc is not available over the next 12 months. Bluejay Diagnostics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bluejay Diagnostics Inc is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, Bluejay Diagnostics Inc’s stock price was USD 1.13. Bluejay Diagnostics Inc’s stock price has changed by -4.24% over the past week, -1.74% over the past month and 0% over the last year.

About Bluejay Diagnostics Inc (BJDX:NSD)

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer tha ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-14 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DXCM DexCom Inc

N/A

USD35.00B 208.91 88.90
ALGN Align Technology Inc

N/A

USD22.57B 36.86 22.02
PODD Insulet Corporation

N/A

USD18.79B 510.75 127.76
LVGO Livongo Health, Inc

N/A

USD14.20B N/A N/A
ABMD ABIOMED Inc

N/A

USD13.35B 61.16 43.54
SWAV Shockwave Medical Inc

N/A

USD10.39B 191.48 154.91
BRKR Bruker Corporation

N/A

USD9.16B 34.34 19.15
IART Integra LifeSciences Holdings

N/A

USD4.69B 27.95 16.47
IRTC iRhythm Technologies Inc

N/A

USD4.55B N/A -39.96
WMGI Wright Medical Group N.V

N/A

USD3.90B N/A 50.67

ETFs Containing BJDX

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -55.86% 20% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -55.86% 20% F 19% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.02B 15% F 9% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 1.37 77% C+ 60% D-
Price / Cash Flow Ratio -5.21 63% D 70% C-
EV/EBITDA -1.26 49% F 65% D
Management Effectiveness  
Return on Equity -79.89% 26% F 16% F
Return on Invested Capital -37.49% 31% F 25% F
Return on Assets -37.66% 19% F 9% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 0.88 89% B+ 80% B-
Short Percent 2.07% 69% D+ 58% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.